The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the ...

The influencer, 26, is participating in a new clinical trial for her rare bile duct cancer ...

In this systematic review and cohort study, researchers aimed to determine whether receipt of guideline-concordant systemic therapy is associated with OS in iCCA patients.

The liver creates a digestive juice called bile and stores it in the gall bladder. While eating, the gall bladder forces the bile through a gall bladder tube called the bile duct. Bile duct cancer, or ...

With the program’s seventh approval in the books, the FDA is illustrating just how speedy it can be with drug reviews that ...

The U.S. Food and Drug Administration has approved Partner Therapeutics' drug for adults with ​a rare form of bile duct ...

At Huntsman Cancer Institute, our experts deliver specialized, multidisciplinary care for bile duct cancer (cholangiocarcinoma). You are supported by a team of specialists including hepatobiliary ...

The FDA has approved zenocutuzumab-zbco as the first drug for certain patients with a rare and aggressive bile duct cancer.

Cholangiocarcinoma better known as bile duct cancer; is a rare but aggressive form of cancer occurring commonly in individuals over the age of 50. The tumors of bile duct are difficult to treat and ...

Bile duct cancer is a rare but aggressive form of cancer, affecting just over 2,000 people in the UK every year. However, incidences of bile cancer are steadily increasing every year – with some ...

Researchers have found that taking aspirin can be connected to a dramatic reduction in bile duct cancer risk. According to them, people who take aspirin have up to 3.5 times lesser chances of ...